CME Group and Nasdaq Extend Exclusive Nasdaq-100 Futures License Through 2039

Go back to CME Group and Nasdaq Extend Exclusive Nasdaq-100 Futures License Through 2039

Nasdaq OMX Group Inc. (NDAQ) PT Raised to $99 at Raymond James, 'Firing on All Cylinders'

July 24, 2025 11:30 AM UTC

Raymond James analyst Patrick O\'Shaughnessy raised the price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ) to $99.00 (from $96.00) while maintaining a Outperform rating.

The analyst comments "We maintain our Outperform rating on Nasdaq following the release of 2Q25 earnings and increase our... More

Raymond James Reiterates Outperform Rating on Nasdaq OMX Group Inc. (NDAQ)

July 24, 2025 8:13 AM UTC

Raymond James analyst Patrick O\'Shaughnessy reiterated an Outperform rating and $96.00 price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ).

The analyst comments "Nasdaq posted strong results in the second quarter with each segment finishing ahead of expectations. Total organic revenue growth of... More

Citi Reiterates Neutral Rating on Nasdaq OMX Group Inc. (NDAQ)

July 24, 2025 8:11 AM UTC

Citi analyst Chris Allen reiterated a Neutral rating and $95.00 price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ).

The analyst comments "NDAQ reported 2Q25 adj. EPS of $0.85 (vs our/Factset consensus est. of $0.83/0.81). Relative to our estimates, net revenue was above our... More

CME Group (CME) PT Raised to $309 at Raymond James

July 23, 2025 12:18 PM UTC

Raymond James analyst Patrick O\\\'Shaughnessy raised the price target on CME Group (NASDAQ: CME) to $309.00 (from $306.00) while maintaining a Outperform rating.

The analyst comments "We maintain our Outperform rating on CME Group following 2Q25 earnings and bump our target... More